xanthorrhizol has been researched along with Mouth Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, JM; Chung, WY; Hwang, JK; Kim, du S; Kim, JY; Park, KK; Seo, JT; Seo, SR | 1 |
1 other study(ies) available for xanthorrhizol and Mouth Neoplasms
Article | Year |
---|---|
Xanthorrhizol induces apoptosis through ROS-mediated MAPK activation in human oral squamous cell carcinoma cells and inhibits DMBA-induced oral carcinogenesis in hamsters.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Squamous Cell; Caspase Inhibitors; Cell Line, Tumor; Cell Survival; Cricetinae; Humans; Male; MAP Kinase Signaling System; Mouth Neoplasms; Neoplasms, Experimental; Phenols; Reactive Oxygen Species | 2013 |